Viewing Study NCT05238493


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2025-12-25 @ 11:16 PM
Study NCT ID: NCT05238493
Status: COMPLETED
Last Update Posted: 2024-06-27
First Post: 2022-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101
Sponsor: Veloxis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module